Stocks quoted in this article:
U.S. stocks are trading modestly lower this afternoon, with the major equity indexes paring their weekly gains amid rising geopolitical tensions. Among the names making notable moves are security and surveillance specialist Digital Ally, Inc. (NASDAQ:DGLY), biotech stock Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), and apparel company Guess?, Inc. (NYSE:GES). Here's a quick look at how DGLY, TKMR, and GES are faring on the charts today.
- DGLY is on the move again today, up 36.1% at $15.63 after landing a $1.1 million order from the Michigan State Police. Digital Ally, Inc. could be benefiting from some short-covering activity, as 11.1% of the equity's float is sold short. However, despite touching an intraday high of $15.75, DGLY could struggle to finish above the $15 level today. The shares have challenged this region on multiple occasions over the past year, but they haven't settled a single day above $15 since September 2013.
- TKMR has jumped 9.5% to trade at $21.62, as traders respond to reports suggesting the Ebola vaccine specialist could be a takeover target. Shares of Tekmira Pharmaceuticals Corporation have rallied roughly 171% year-to-date, and they're currently attempting to find their footing atop the recently troublesome $20 level. Analysts are expecting TKMR to clear this hurdle over the long run, as the stock's average 12-month price target weighs in at $26.96.
- GES has taken a dive post-earnings, with the shares off 9.1% at $23.32 this afternoon. Guess?, Inc. has lost about one-quarter of its value in 2014, and is now staring up at the formerly supportive $25 level. In fact, the stock tagged a fresh annual low of $23.24 earlier in the session. The retailer's disappointing outlook has triggered price-target cuts today from no fewer than six brokerage firms, with particularly bearish notes rolling in from ISI Group and Mizuho Securities -- both of which lowered their targets to $22. Ahead of last night's earnings report, GES was already surrounded by skepticism. The security's short-to-float ratio stands at 12.1%, only one analyst out of seven deems it a "buy," and -- based on the Schaeffer's put/call open interest ratio (SOIR) of 2.01 -- puts more than double calls among options set to expire in three months.